According to the study, medications known as selective serotonin reuptake inhibitors, or SSRIs, are frequently used to treat seasonal affective disorder. There are several branded and generic medications available on the seasonal affective disorder therapeutics market size however, buproban and citalopram continue to sell at a relatively higher rate. FMI credits this dominance to the widely accessible …
Tag Archives: Seasonal Affective Disorder Therapeutics Market Sales
Seasonal Affective Disorder Therapeutics Market Set to Approach US$ 1.1 Billion by 2028-FMI Study
The global seasonal affective disorder therapeutics market is expected to grow at a 4.3% CAGR. The market is currently valued at US$ 848.2 million and is expected to reach US$ 1.1 billion by the end of 2028. Popular drugs preferred in seasonal affective disorder therapeutics include selective serotonin reuptake inhibitors (SSRIs), according to the report. While generics …